tirzepatide ndc ZEPBOUND® Prefilled Syringe (Tirzepatide) 12.5mg/.5ml FDA Says Shortage of GLP-1

Enhanced Energy and Reduced Cravings As weight decreases, patients report reduced food obsession and enhanced energy

Instead of the standard escalation from 0.25 mg weekly, this protocol starts at 0.125 mg twice weekly and increases gradually

If sleep disruption persists for more than 3 weeks, consider switching to morning injection

Eating strategies by treatment phase Your relationship with food changes as you progress through tirzepatide treatment

Genesis Lifestyle Medicine

Ask whether your hypothyroidism is well controlled, whether you have any thyroid cancer risk factors, and when your thyroid labs should be checked after starting treatment